The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment

scientific article published on 18 January 2016

The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5603/KP.A2015.0250
P698PubMed publication ID26779846

P50authorJacek BilQ37842832
Robert GilQ68692932
Tomasz PawlowskiQ73299545
P2093author name stringWojciech Jabłoński
Jacek Jańczak
Leszek Kołakowski
Nabijon Yuldashev
Piotr Paliński
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectcoronary artery diseaseQ844935
P304page(s)627-633
P577publication date2016-01-18
P1433published inKardiologia PolskaQ2775982
P1476titleThe use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment
P478volume74

Reverse relations

cites work (P2860)
Q41270451A Combination of Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in the Treatment of Multivessel Coronary Artery Disease
Q38967027Bioresorbable vascular scaffolds - basic concepts and clinical outcome
Q26741147Bioresorbable vascular scaffolds technology: current use and future developments
Q38822091Bioresorbable vascular scaffolds-what does the future bring?
Q92445854Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-years Results from the GABI-R Registry
Q50663676Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.

Search more.